Director sells shares under 10b5-1 plans at Alignment Healthcare (ALHC)

Rhea-AI Filing Summary

Alignment Healthcare, Inc. submitted a Rule 144 notice relating to planned sales of Common Stock by a selling holder under existing 10b5-1 Sales Plan arrangements. The filing lists multiple executed or scheduled dispositions by Dawn Maroney, including sales of 100,000 shares on 01/02/2026 and 228,152 shares on 01/06/2026. Shares outstanding were 204,296,493 as of 03/11/2026.

Insights

Insider Transactions Analyst

Routine, pre-arranged insider dispositions under a 10b5-1 plan are reported.

The filing lists multiple sales executed or scheduled under a 10b5-1 Sales Plan for Dawn Maroney, with dated entries and share counts such as 100,000 (01/02/2026) and 228,152 (01/06/2026). These entries reflect dispositions rather than grants.

The primary dependency is the existence and terms of the 10b5-1 plan; the filing documents plan-based transactions but does not alter outstanding share count. Subsequent filings or trade reports will show final proceeds and any remaining planned sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	E-Trade Finance PO Box 101600 Arlington VA 22210-4600	30000	553200	204296493	03/11/2026	Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/08/2022	The Common Stock was acquired through the vesting of restricted stock units granted on 03/08/2022 under the Issuer's 2021 Equity Incentive Plan	Alignment Healthcare, Inc. (Issuer)			51738	03/08/2022	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for Dawn Maroney 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	02/17/2026	30000	618990
10b5-1 Sales Plan for Dawn Maroney 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	01/15/2026	30000	674450.94
10b5-1 Sales Plan for Dawn Maroney 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	01/06/2026	228152	4867600.1
10b5-1 Sales Plan for Dawn Maroney 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	01/02/2026	100000	2003450
Dawn Maroney 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	12/29/2025	282070	5286747.38
10b5-1 Sales Plan for Dawn Maroney 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	12/15/2025	113319	2267150.57
10b5-1 Sales Plan for Dawn Maroney 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	12/12/2025	16681	333960.29

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Alignment Healthcare's (ALHC) Form 144 disclose?

The Form 144 discloses planned or executed sales of Common Stock by a selling holder under 10b5-1 plans. It lists dated transactions and share counts such as 100,000 (01/02/2026) and 228,152 (01/06/2026).

Who is the selling holder named in the ALHC filing?

The filing identifies Dawn Maroney as the selling holder associated with the listed transactions. Multiple entries are labeled as executed under a 10b5-1 Sales Plan in the filing.

How many shares does the filing show outstanding for ALHC?

The document states shares outstanding were 204,296,493 as of 03/11/2026. This figure is presented in the securities information section of the filing.

Are the transactions described as 10b5-1 plan sales?

Yes. Several entries are explicitly labeled "10b5-1 Sales Plan for Dawn Maroney" with dates and share amounts, indicating pre-arranged trading plan dispositions.

Can I see examples of transaction sizes in the filing?

Examples in the filing include a sale of 100,000 shares on 01/02/2026 and 228,152 shares on 01/06/2026. Multiple other dated entries with amounts are listed.